Cargando…
Towards Better Delivery of Cannabidiol (CBD)
Cannabidiol (CBD) has substantial therapeutic potential, but its development as an effective drug by the pharmaceutical industry is hindered by intrinsic characteristics such as low bioavailability, low water solubility, and variable pharmacokinetic profiles. Importantly, lack of patentability of th...
Autores principales: | Millar, Sophie Anne, Maguire, Ryan Francis, Yates, Andrew Stephen, O’Sullivan, Saoirse Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558665/ https://www.ncbi.nlm.nih.gov/pubmed/32872355 http://dx.doi.org/10.3390/ph13090219 |
Ejemplares similares
-
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018) -
Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022) -
A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol
por: Sultan, Salahaden R., et al.
Publicado: (2017) -
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014) -
The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)